Konica Minlota

TAKE Solutions Sustains Growth Momentum with Q3 FY18

February, 10, 2018

TAKE Solutions Ltd. announced its financial results for Q3 FY18. The Company carried forward the momentum witnessed in Q2 FY18, reporting strong Q3 revenue and profit figures of INR 4,080 Mn and INR 411 Mn.

Srinivasan H R, Vice Chairman and Managing DirectorTAKE Solutions said, “This quarter has witnessed strong business growth as can be seen in the financial results. In response to the emerging growth possibilities we are delighted to announce a preferential allotment of INR 250 crores to the promoters. The funds raised through this preferential issue will be used to capitalize on our opportunities and scale our business in the Clinical and Regulatory spaces inorganically through strategic acquisitions in North America and Europe markets.”

Highlights of the quarter:

  • EBITDA grew 15.2% in INR Y-o-Y
  • Revenue saw a growth 18.9% in INR Y-o-Y.
  • Life Sciences revenue grew by 25.4 % (INR) Y-o-Y.
  • Customer base of small and medium pharma for PharmaReady software has crossed 150 and climbing steadily
  • Scales BA/BE business with an 80 bedded Clinical Pharmacology Unit which will be ready to commence operations soon
  • Aligns all capabilities to digitize research and development of life sciences
Share Your Views - post Your Comments Below

DT encourage Readers to go for verification process for security reasons.

Max Characters 1000.

We request you not to post comments that are obscene, libellous, slanderous or in flammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community. Any offensive comments will not be published and will be forwarded to cyber crime department.

Posted Comments
There are no comments yet.
Reve Banner